Hydro Power Plant Prepared by: Nimesh Gajjar. Introduction hydrology cycle.swf.
Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas...
-
Upload
gervase-potter -
Category
Documents
-
view
221 -
download
2
Transcript of Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas...
![Page 1: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/1.jpg)
Aakash H. Gajjar, MD, FACSAssistant Professor of Surgery
Colon & Rectal SurgeryUniversity of Texas Medical Branch
Galveston, TexasFebruary 10th, 2014
The ‘Ins & OUTS’ of ColoRECTAL Cancer
![Page 2: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/2.jpg)
Homer’s Odyssey
• Homer.mov
![Page 3: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/3.jpg)
ANATOMY
![Page 4: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/4.jpg)
WHAT IS CANCER?• Cells that become abnormal and divide without control -> growth -> tumor
• Colon and Recal Cancer (CRC) is the 3rd most common cancer
• Prostate and lung in men; breast and lung in women
WHO IS AT RISK?• Age
• Personal history of polyps or cancer
• Family history
• Inflammatory Bowel Disease (IBD)
• Diet (red and processed meats & low
fruits, grains and vegetables), Smoking, Lack of Exercise
![Page 5: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/5.jpg)
Adenoma–Carcinoma Sequence
![Page 6: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/6.jpg)
![Page 7: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/7.jpg)
COLON & RECTAL CANCER INCIDENCE• UNITED STATES in 2010
• New cases: 102,900 (colon); 39,670 (rectal) (Total: 142,570)
• Deaths: 51,370 (colon and rectal combined)
• 2004-2008: average age of diagnosis : 70 years (SEER database)
• 0.1% under 20
• 1.1% ages 20-34
• 3.9% ages 35-44
• 12.8% ages 45-54
• 19.6% ages 55-64
• 1% ages 65-74
• 26.2% ages 75-84
• 12.2% ages 85+
![Page 8: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/8.jpg)
COLON & RECTAL CANCER MORTALITY• UNITED STATES in 2010
• New cases: 102,900 (colon); 39,670 (rectal) (Total: 142,570)
• Deaths: 51,370 (colon and rectal combined)
• 2003-2007: average age at death : 75 years (SEER database)
• 0.0% under 20
• 0.6% ages 20-34
• 2.4% ages 35-44
• 8.1% ages 45-54
• 15.6% ages 55-64
• 22.2% ages 65-74
• 30.4% ages 75-84
• 20.6% ages 85+
![Page 9: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/9.jpg)
COLORECTAL CANCER TREND IN UNITED STATES
![Page 10: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/10.jpg)
SCREENING OPTIONS• Digital Rectal Exam (DRE)
• Fecal Occult Blood Test (FOBT)
• Sigmoidoscopy
• Colonoscopy
• Virtual colonoscopy (computerized tomographic colonography)
• Double Contrast Barium Enema (DCBE)
• ABNORMAL COLONOSCOPY? -> REFERRAL TO SURGEON
• Staging work-up
• Carcinoembryonic antigen (CEA)
![Page 11: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/11.jpg)
STAGING SYSTEM - TNM• T = Tumor (penetration of tumor in wall) T1, T2, N0, M0 = Stage I
• N = Node Status (any spread to lymph nodes) T3, T4, N0, M0 = Stage II
• M = Metastasis (spread to any other organ) Any N, M0 = Stage III
Any M = Stage IV
![Page 12: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/12.jpg)
COLON CANCER
![Page 13: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/13.jpg)
COLON CANCER STAGING VS. SURVIVAL
![Page 14: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/14.jpg)
HOW ARE COLON AND RECTAL CANCER TREATED?• DIFFERENTLY, BUT….SIMILARLY…How can that be? 2 FLAVORS
• Colon Cancer – staging (CT)
• Surgery (open vs. laparoscopic)
• Adjuvant chemotherapy (after surgery) based on stage (III and IV)
• Stage II – remains controversial - American Society of Clinical Oncology does not recommend adjuvanct chemotherapy, however, may recommend if inadequate node sampling, T4 lesions, perforation, or poorly differentiated.
![Page 15: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/15.jpg)
SURGICAL OPTIONS
![Page 16: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/16.jpg)
HOW ARE COLON AND RECTAL CANCER TREATED?• Rectal Cancer – staging (US, MRI, CT)
• +/- Neoadjuvant chemo/radiation (before surgery) based on stage (Stage II, III)
• Improves local control, disease-free survival, and overall survival
• Swedish Rectal Cancer Trial – pre-op XRT or no XRT?
• showed pre-op XRT had improvement in local control (89% vs. 73%) and overall survival (58% vs. 48%)
• European Trial – Preop XRT or Preop chemo/XRT?
• Combined had lower recurrence rate (8.1% vs 16.5%)
• Similar 5-year overall survival
• German Rectal Cancer Trial – pre-op chemo/XRT or post-op chemo/XRT? - T3/T4, or +N
• Pre-op chemo/XRT had lower local recurrence (6% vs 13%)
• Same 5-year disease-free and overall survival rates
![Page 17: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/17.jpg)
HOW ARE COLON AND RECTAL CANCER TREATED?• Surgery (open vs. laparoscopic) – LOCATION, LOCATION, LOCATION…
• TAE (TransAnal Excision) – T1 lesions
• LAR (Low Anterior Resection)
• APR (Abdominal Perineal Resection)
• Adjuvant chemo/radiation (after surgery) based on final pathology
![Page 18: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/18.jpg)
DRUGS APPROVED FOR COLON CANCER• Adrucil (Fluorouracil)Avastin (Bevacizumab)BevacizumabCamptosar (Irinotecan Hydrochloride)Capecitabine
CetuximabEfudex (Fluorouracil)Eloxatin (Oxaliplatin)Erbitux (Cetuximab)Fluoroplex (Fluorouracil)FluorouracilFOLFIRIFOLFOXIrinotecan HydrochlorideLeucovorin CalciumOxaliplatinPanitumumabVectibix (Panitumumab)Wellcovorin (Leucovorin Calcium)Xeloda (Capecitabine)
![Page 19: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/19.jpg)
DRUGS APPROVED FOR RECTAL CANCER• Adrucil (Fluorouracil)Avastin (Bevacizumab)BevacizumabCamptosar (Irinotecan Hydrochloride)Cetuximab
Efudex (Fluorouracil)Erbitux (Cetuximab)Fluoroplex (Fluorouracil)FluorouracilFOLFIRIFOLFOXIrinotecan HydrochloridePanitumumabVectibix (Panitumumab)
![Page 20: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/20.jpg)
COMMON CHEMOTHERAPEUTIC REGIMENS• 5-FU w/ Levamisole (gold standard until 1996) – Stage III/IV recurrence 41%, death 31%
• 5-FU w/ Leucovorin (increased overall survival 78% to 83%)
• Oxaliplatin (FOLFOX, XELOX) (MOSAIC Trial – compared to 5-FU/Leucovorin) – 1st line
• Irinotecan (FOLFIRI, IFL, IROX) (FOLFOX > FOLFIRI) – 2nd line
• Bevacizumab (AVASTIN®) – Stage IV- 1st biologic- blocks angiogenesis
• Cetuximab (ERBITUX®) – Stage IV
• NOT WITHOUT THEIR OWN COMPLICATIONS!!!! DECISION IS BASED ON AN INDIVIDUAL BASIS based on overall health. RISKS vs. BENEFITS (diarrhea, nausea, emesis, alopecia, neutropenia, neuropathy) – 50% will not complete treatment
![Page 21: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/21.jpg)
SUMMARY
•Based on rates from 2005-2007, ~5% of men & women born today will be diagnosed with CRC sometime during their lifetime. (1 in 20 individuals in this room)
•Screening is extremely important for prevention of colon or rectal cancer
•Colon Cancer is Detectable, Treatable, and Beatable
•Be proactive regarding your health – you only have one life
![Page 22: Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.](https://reader030.fdocuments.us/reader030/viewer/2022012910/56649cd75503460f9499febc/html5/thumbnails/22.jpg)
ADDITIONAL INFORMATION• http://www.cancer.gov/cancertopics/types/colon-and-rectal
• http://seer.cancer.gov/